Cargando…
A Case of Autoimmune Hemolytic Anemia after the First Dose of COVID-19 mRNA-1273 Vaccine with Undetected Pernicious Anemia
By this time, multiple vaccines have been approved to limit the spread of SARS-CoV-2 worldwide. These include new-generation vaccines that contain mRNA of the target organism. Some common side effects were identified and reported during phase 3 clinical trials of vaccination, but more rare adverse e...
Autores principales: | Jaydev, Fnu, Kumar, Vinod, Khatri, Jaikumar, Shahani, Shobha, Beganovic, Sead |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799952/ https://www.ncbi.nlm.nih.gov/pubmed/35103106 http://dx.doi.org/10.1155/2022/2036460 |
Ejemplares similares
-
Pernicious Anemia with Autoimmune Hemolytic Anemia: A Case Report and Literature Review
por: Yeruva, Sri Lakshmi Hyndavi, et al.
Publicado: (2016) -
A case of pernicious anemia requiring differential diagnosis of autoimmune hemolytic anemia complication
por: Todo, Saki, et al.
Publicado: (2017) -
A Rare Case of Acquired Hemolytic Anemia and Pancytopenia Secondary to Pernicious Anemia
por: Sasi, Sreethish, et al.
Publicado: (2020) -
Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine
por: Mesina, Flordeluna Z.
Publicado: (2022) -
Autoimmune Hemolytic Anemia After Cyanocobalamin Replacement in a Patient With a Previous Diagnosis of Pernicious Anemia: A Case Report
por: Mejia Buritica, Leonardo, et al.
Publicado: (2020)